L3Harris Technologies, Inc. · LHX · FY2025 Q3 · Calendar Q4 2025
L3Harris: Strong demand, higher execution and award risks
The supplied analysis supports a constructive operating picture for L3Harris, led by defense, missile, international and space demand. The case remains dependent on converting backlog and planned capacity into execution while navigating award timing, appropriations and supply-chain risks.
Earnings scorecard
Reported versus consensusMarket reaction
prior-close to event-session closeAsk FN2 about LHX FY2025 Q3
Transcript, numbers and history already loadedFree account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
Compared with the prior-quarter analysis, the current analysis emphasizes continued organic growth and operating execution, a still-positive book-to-bill, expanded manufacturing plans and additional AI-enabled systems. It also adds sharper focus on Golden Dome award uncertainty, ISR capacity and competitive pressure in solid-rocket motors.
Guidance delta
The supplied analysis characterizes guidance sentiment as raised; no new numerical guidance delta is supplied here.
Key takeaways
- Management highlighted 10% organic revenue growth, a 15.9% operating margin and a 1.2 book-to-bill.
- Missile-defense demand, solid-rocket motors, international programs and space systems were the main growth drivers.
- The company is expanding manufacturing capacity and emphasizing AI-enabled, software-defined mission systems.
- Risks include award timing, appropriations uncertainty, supply-chain constraints and competitive pressure.
Management priorities
- Expand manufacturing across multiple U.S. sites
- Ramp PAC-3 solid-rocket motor and interceptor production
- Scale AI-enabled and software-defined mission systems
- Advance satellite and space-program activity
Follow LHX with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Analyst 52W Price Targets
Latest persisted target per named analyst; persisted previous close from FN2's market snapshot as of Sep 29, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Bernstein | Outperform | Outperform | Maintain | Sep 23, 2026 |
| UBS | Neutral | Neutral | Maintain | Aug 3, 2026 |
| Susquehanna | Positive | Positive | Maintain | Jul 31, 2026 |
| BNP Paribas | Neutral | Neutral | Maintain | Jul 30, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Feb 5, 2026 |
| Citigroup | Buy | Buy | Maintain | Feb 5, 2026 |
| Morgan Stanley | Overweight | Overweight | Maintain | Feb 2, 2026 |
| RBC Capital | Sector Perform | Sector Perform | Maintain | Jan 30, 2026 |
| Truist Securities | Buy | Buy | Maintain | Oct 15, 2025 |
| Barclays | Overweight | Overweight | Maintain | Jul 29, 2025 |
| Baird | Outperform | Outperform | Maintain | Jul 25, 2025 |
| Goldman Sachs | Buy | Sell | Upgrade | Apr 11, 2025 |
| Wells Fargo | Overweight | Overweight | Maintain | Apr 8, 2025 |
| Jefferies | Buy | Buy | Maintain | Mar 31, 2025 |
| B of A Securities | Buy | Buy | Maintain | Feb 4, 2025 |
| Raymond James | Market Perform | Outperform | Downgrade | Jan 2, 2025 |
| Deutsche Bank | Hold | Hold | Maintain | Jan 2, 2025 |
| Argus Research | Buy | Hold | Upgrade | Nov 26, 2024 |
| Wolfe Research | Outperform | Peer Perform | Upgrade | Oct 10, 2024 |
| Alembic Global | Overweight | Neutral | Upgrade | Apr 22, 2024 |
| Credit Suisse | Outperform | Outperform | Maintain | May 1, 2023 |
| Cowen & Co. | Outperform | Outperform | Maintain | Jan 12, 2023 |
| Benchmark | Hold | Buy | Downgrade | Apr 27, 2021 |
| Seaport Global | Buy | Buy | Maintain | May 19, 2020 |
| SunTrust Robinson Humphrey | Buy | Buy | Maintain | Apr 16, 2020 |
| CFRA | Buy | Buy | Maintain | Feb 4, 2020 |
| Buckingham Research | Buy | Buy | Maintain | Aug 8, 2019 |
| Vertical Research | Buy | Buy | Maintain | Jul 3, 2019 |
| Argus | Buy | Buy | Maintain | Apr 4, 2018 |
| Sterne Agee | Buy | Neutral | Upgrade | Feb 9, 2015 |
| Stifel Nicolaus | Hold | Hold | Maintain | May 21, 2013 |
| Oppenheimer | Underperform | Perform | Downgrade | Mar 6, 2013 |
| Lazard | Sell | Neutral | Downgrade | Oct 15, 2012 |
Named analyst price targets
Upside is calculated against the persisted previous close $237.7. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Guggenheim | Analyst unavailable | $365 | $248.93 | +53.6% | Sep 14, 2026 |
| Jefferies | Analyst unavailable | $315 | $262.17 | +32.5% | Aug 26, 2026 |
| UBS | Gavin Parsons | $323 | $343.92 | +35.9% | Jan 14, 2026 |
| Truist Financial | Michael Ciarmoli | $364 | $343.76 | +53.1% | Jan 14, 2026 |
| Vertical Research | Robert Stallard | $355 | $350.48 | +49.3% | Jan 13, 2026 |
| Morgan Stanley | Analyst unavailable | $367 | $288.5 | +54.4% | Dec 16, 2025 |
| Morgan Stanley | Analyst unavailable | $350 | $299.99 | +47.2% | Oct 15, 2025 |
| Susquehanna | Charles Minervino | $300 | $260.96 | +26.2% | Jul 14, 2025 |
| Morgan Stanley | Kristine Liwag | $260 | $230.68 | +9.4% | Dec 19, 2024 |
| Jefferies | Sheila Kahyaoglu | $295 | $245.07 | +24.1% | Oct 30, 2024 |
| Citigroup | Jonathan Raviv | $291 | $244.52 | +22.4% | Oct 24, 2024 |
| Bernstein | Douglas Harned | $289 | $242.35 | +21.6% | Oct 11, 2024 |
| Wolfe Research | Myles Walton | $300 | $241.64 | +26.2% | Oct 10, 2024 |
| Deutsche Bank | Scott Deuschle | $250 | $244.66 | +5.2% | Oct 3, 2024 |
| Jefferies | Sheila Kahyaoglu | $275 | $230.09 | +15.7% | Aug 23, 2024 |
| RBC Capital | Sector Perform | $240 | $227.88 | +1.0% | Aug 14, 2024 |
| Morgan Stanley | Kristine Liwag | $257 | $230.62 | +8.1% | Aug 9, 2024 |
| Deutsche Bank | Scott Deuschle | $257 | $243.27 | +8.1% | Jul 26, 2024 |
| Deutsche Bank | Bryan Keane | $295 | $222.45 | +24.1% | Jun 19, 2024 |
| Wells Fargo | Matthew Akers | $245 | $214.75 | +3.1% | May 7, 2024 |
| Barclays | David Strauss | $245 | $217.06 | +3.1% | Apr 30, 2024 |
| RBC Capital | Ken Herbert | $250 | $215.63 | +5.2% | Apr 29, 2024 |
| US Capital Advisors | Peter Skibitski | $238 | $208.14 | +0.1% | Apr 22, 2024 |
| Robert W. Baird | Peter Arment | $219 | $180.12 | -7.9% | Oct 31, 2023 |
| Raymond James | Brian Gesuale | $210 | $174.36 | -11.7% | Oct 30, 2023 |
| Wells Fargo | Jonathan Raviv | $193 | $175.98 | -18.8% | Sep 18, 2023 |
| Wells Fargo | Matthew Akers | $209 | $172.72 | -12.1% | Sep 18, 2023 |
| Robert W. Baird | Peter Arment | $222 | $203.33 | -6.6% | Jul 26, 2023 |
| Credit Suisse | Scott Deuschle | $240 | $194.68 | +1.0% | Mar 27, 2023 |
| Wells Fargo | Analyst unavailable | $230 | $214.77 | -3.2% | Feb 1, 2023 |
| Cowen & Co. | Analyst unavailable | $240 | $199.91 | +1.0% | Jan 12, 2023 |
| Wells Fargo | Analyst unavailable | $219 | $201.95 | -7.9% | Jan 11, 2023 |
| Morgan Stanley | Analyst unavailable | $278 | $218.04 | +17.0% | Dec 15, 2022 |
| J.P. Morgan | Analyst unavailable | $250 | $215.61 | +5.2% | Dec 12, 2022 |
| RBC Capital | Ken Herbert | $285 | $231.97 | +19.9% | Aug 30, 2022 |
| Jefferies | Sheila Kahyaoglu | $300 | $235.21 | +26.2% | May 3, 2022 |
| Susquehanna | Analyst unavailable | $298 | $232.38 | +25.4% | May 2, 2022 |
| Raymond James | Analyst unavailable | $290 | $236.2 | +22.0% | Apr 29, 2022 |
| Jefferies | Sheila Kahyaoglu | $320 | $250.11 | +34.6% | Mar 14, 2022 |
| J.P. Morgan | Seth Seifman | $237 | $209 | -0.3% | Feb 1, 2022 |
| Susquehanna | Charles Minervino | $255 | $209 | +7.3% | Feb 1, 2022 |
| Wolfe Research | Michael Maugeri | $266 | $227.86 | +11.9% | Jan 14, 2022 |
| Goldman Sachs | Noah Poponak | $207 | $219.25 | -12.9% | Sep 23, 2021 |
| Cowen & Co. | Gautam Khanna | $250 | $219.05 | +5.2% | Sep 16, 2021 |
| Credit Suisse | Robert Spingarn | $254 | $226.35 | +6.9% | Aug 4, 2021 |
Track every rating change on LHX the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationL3Harris Technologies, Inc. is a prominent technology firm specializing in aerospace and defense, delivering vital, high-stakes solutions to governmental and commercial clients across the globe. Its diverse operations are organized into several key segments: The Integrated Mission Systems division is responsible for providing versatile intelligence, surveillance, and reconnaissance (ISR) platforms, alongside various communication technologies. This unit also offers comprehensive support for fleet management, as well as the development, modification, and routine maintenance of sensors for ISR and airborne operations. Furthermore, it develops and integrates specialized mission systems tailored for naval vessels and maritime operations, including sophisticated signals and multi-intelligence platforms, autonomous surface and undersea vehicles, and advanced power and ship control electronics. Cutting-edge electro-optical and infrared technologies are also part of its offerings.…
Historical context
All LHX earningsIndustrials peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| CTAS Cintas Corporation | FY2027 Q1 · Calendar Q3 2026 | +3.0% | -3.4% | Cintas raises FY2027 guidance as Q1 growth broadens |
| PAYX Paychex, Inc. | FY2027 Q1 · Calendar Q3 2026 | +1.5% | -8.8% | Paychex maintains FY27 outlook as PEO and AI momentum strengthen |
| FPS Forgent Power Solutions, Inc. | FY2026 Q4 · Calendar Q3 2026 | +4.3% | +9.5% | Forgent Power Solutions pairs record results with an aggressive FY27 buildout |
| CPRT Copart, Inc. | FY2026 Q4 · Calendar Q3 2026 | -8.7% | -2.6% | Copart pairs international growth with ACV investment amid higher costs |
| SUNB Sunbelt Rentals Holdings Inc | FY2027 Q1 · Calendar Q3 2026 | +19.2% | +5.9% | Sunbelt raises FY27 outlook as specialty rental demand accelerates |
| FRO Frontline Plc | FY2026 Q2 · Calendar Q3 2026 | +8.0% | +1.0% | Frontline posts a record quarter as tanker rates remain elevated |
Latest beats and misses
Who reports nextBeat on EPS
- COSTFY2026 Q4 · September 24, 2026+3.2% EPS+2.9% move
- SNXFY2026 Q3 · September 24, 2026+20.9% EPS-9.9% move
- DRIFY2027 Q1 · September 24, 20260.0% EPS-3.0% move
- CTASFY2027 Q1 · September 23, 2026+3.0% EPS-3.4% move
- PAYXFY2027 Q1 · September 23, 2026+1.5% EPS-8.8% move
- GISFY2027 Q1 · September 23, 2026+4.6% EPS+1.0% move
Get the LHX recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2026-07-26T00:36:15.940040+00:00
- Polygon adjusted daily market bars · 2026-09-29T08:16:10.843442+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-09-29T08:16:10.840564+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-09-29. For educational purposes only; not investment advice.